2009 influenza a H1N1 infections: Delays in starting treatment with oseltamivir were associated with a more severe disease

Pediatric Infectious Disease Journal

Volumn 30, Issue 7, 2011, Pages 622-625

  Launes, Cristian ^a,b   García García, Juan José ^a   Jordán, Iolanda ^a   Martínez Planas, Aina ^a   Selva, Laura ^a   Muñoz Almagro, Carmen ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Hospital Sant Joan de Déu de Barcelona   (Spain)

Author keywords

2009 influenza A H1N1; children; oseltamivir

Indexed keywords

OSELTAMIVIR;

2009 H1N1 INFLUENZA; ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; HOSPITAL ADMISSION; HUMAN; INFLUENZA VIRUS A H1N1; INTENSIVE CARE; MAJOR CLINICAL STUDY; MORTALITY; PANDEMIC; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY FAILURE; SCHOOL CHILD; THERAPY DELAY;

EID: 79959691161     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182093397     Document Type: Article

References (10)

1. Larcombe PJ, Moloney SE, Schmidt PA. Pandemic (H1N1) 2009: a clinical spectrum in the general paediatric population. Arch Dis Child. 2010. Available at: http://adc.bmj.com/cgi/pmidlookup? view-long&pmid- .19906639. Accessed April 25, 2010.
2. Hackett S, Hill L, Patel J, et al. Clinical characteristics of paediatric H1N1 admissions in Birmingham, United Kingdom. Lancet. 2009;374:605.
3. Lister P, Reynolds F, Parslow R, et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet. 2009;374: 605-607.
4. Libster R, Bugna J, Coviello S, et al. Pediatric hospitalizations associated with 2009 pandemic influenza A (H1N1) in Argentina. N Engl J Med. 2010;362:45-55.
5. Subdirecció General de Vigilància i Resposta a Emergències en Salut Pública. Generalitat de Catalunya. Departament de Salut. Pla d'informació de les infeccions respiratòries agudes a Catalunya. Temporada gripal 2009-2010. Full informatiu núm. 13.-Generalitat de Catalunya-. Available at: http://www.gencat.cat/salut/depsalut/html/ca/dir2097/spfi.pdf. Accessed June 1, 2010.
6. World Health Organization. Human Infection With Pandemic (H1n1) 2009 Virus: Updated Interim WHO Guidance on Global Surveillance. WHO. Available at: http://www.who.int/csr/disease/swineflu/guidance/surveillance/WHO- case-definition-swine-flu-2009-04-29.pdf. Accessed April 14, 2010.
7. Center for Drug Evaluation and Research (CDER), US Department of Health and Human Services, Food and Drug Administration. Guidance for Industry Community-Acquired Bacterial Pneumonia: Developing Drugs for Treatment. Food and Drug Administration. Available at: http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm123686. pdf. Accessed June 1, 2010.
8. Sánchez-Torrent L, Triviño-Rodriguez M, Suero-Toledano P, et al. Novel influenza A (H1N1) encephalitis in a 3-month-old infant. Infection. 2010; 38:227-229.
9. Centers for Disease Control and Prevention. Emerging Infections Program. Influenza laboratory-confirmed cumulative hospitalization rates 2009-2010. Weekly influenza surveillance report: 2009-2010 Influenza Season Week 20 ending May 22, 2010. CDC. Available at: http://www. cdc.gov/flu/weekly/. Accessed June 10, 2010.
10. Okada T, Morozumi M, Matsubara K, et al. Characteristic findings of pediatric inpatients with pandemic (H1N1) 2009 virus infection among severe and nonsevere illnesses. J Infect Chemother. 2010. Available at: http://dx.doi.org/10.1007/s10156-010-0115-z. Accessed September 15, 2010.